Cargando…
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
Head and neck cancers, including those of the lip and oral cavity, nasal cavity, paranasal sinuses, oropharynx, larynx and nasopharynx represent nearly 700,000 new cases and 380,000 deaths worldwide per annum, and account for over 10,000 annual deaths in the United States alone. Improvement in outco...
Autores principales: | Cohen, Ezra E. W., Bell, R. Bryan, Bifulco, Carlo B., Burtness, Barbara, Gillison, Maura L., Harrington, Kevin J., Le, Quynh-Thu, Lee, Nancy Y., Leidner, Rom, Lewis, Rebecca L., Licitra, Lisa, Mehanna, Hisham, Mell, Loren K., Raben, Adam, Sikora, Andrew G., Uppaluri, Ravindra, Whitworth, Fernanda, Zandberg, Dan P., Ferris, Robert L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6632213/ https://www.ncbi.nlm.nih.gov/pubmed/31307547 http://dx.doi.org/10.1186/s40425-019-0662-5 |
Ejemplares similares
-
Neoadjuvant immunotherapy of locoregionally advanced solid tumors
por: Tarhini, Ahmad A, et al.
Publicado: (2022) -
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma
por: Govindan, Ramaswamy, et al.
Publicado: (2022) -
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
por: Brahmer, Julie R., et al.
Publicado: (2018) -
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
por: Kamat, Ashish M., et al.
Publicado: (2017) -
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma
por: Shah, Nina, et al.
Publicado: (2020)